JPM26:随着来那卡帕韦势头增强,吉利德以“强势地位”寻求新交易
JPM26: As lenacapavir momentum builds, Gilead eyes new deals from a 'position of strength'
生物技术与制药领域的最新动态
JPM26: As lenacapavir momentum builds, Gilead eyes new deals from a 'position of strength'
#JPM26: Day 3 at the JP Morgan Healthcare Conference
#JPM26: Q&A with Bristol Myers Squibb CEO Chris Boerner on 2026 outlook
Company Profile – Thermo Fisher Scientific - pharmaphorum
Illumina unveils massive cell atlas to speed up drug discovery - San Diego Union-Tribune
Prefoldin 5 is a microtubule-associated protein that suppresses Tau aggregation and neurotoxicity
Insights from aquaporin structures into drug-resistant sleeping sickness
The RNA-binding protein HuR modulates the expression of the disease-linked CCL2 rs1024611G-rs13900T haplotype
Fish CDK2 recruits Dtx4 to degrade TBK1 through ubiquitination in the antiviral response
A unifying account of replay as context-driven memory reactivation
Afadin sorts different retinal neuron types into accurate cellular layers
Nonlinear transcriptional responses to gradual modulation of transcription factor dosage
Secreted exosomes induce filopodia formation
Building Intelligent Workflows for the Multiomic Era - Genetic Engineering and Biotechnology News
Building Intelligent Workflows for the Multiomic Era - Genetic Engineering and Biotechnology News
Viega North America hires Thermo Fisher Scientific VP as COO - BizWest
Illumina CEO Sees Big Growth Opportunity in China - Bloomberg.com
JPM26: Biotech’s M&A lift, the ‘new’ Biogen and Merck’s $70B target
FDA delays decision on expanding label for Travere's kidney disorder drug
FDA requests flu vaccine label updates to include febrile seizure risk